Clinical and metabolic effects of drospirenone-estradiol in menopausal women: a prospective study. (Q48334580)

10 February 2018

title

Clinical and metabolic effects of drospirenone-estradiol in menopausal women: a prospective study. (English)

1 reference

10 February 2018

author name string

M Gambacciani

1

1 reference

10 February 2018

G Rosano

2

1 reference

10 February 2018

B Cappagli

3

1 reference

10 February 2018

A Pepe

4

1 reference

10 February 2018

C Vitale

5

1 reference

10 February 2018

A R Genazzani

6

1 reference

10 February 2018

publication date

27 October 2010

1 reference

10 February 2018

published in

Climacteric

1 reference

10 February 2018

volume

14

1 reference

10 February 2018

issue

1

1 reference

10 February 2018

page(s)

18-24

1 reference

10 February 2018

IMS updated recommendations on postmenopausal hormone therapy

cites work

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.520099

Postmenopausal hormone therapy and mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.520099

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.520099

Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.520099

Management of cardiovascular risk in the perimenopausal women: a consensus statement of European cardiologists and gynecologists

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.520099

Mortality associated with hormone replacement therapy in younger and older women: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.520099

Drospirenone: pharmacology and pharmacokinetics of a unique progestogen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.520099

Estradiol and drospirenone for climacteric symptoms in postmenopausal women: a double-blind, randomized, placebo-controlled study of the safety and efficacy of three dose regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.520099

Long-term safety of drospirenone-estradiol for hormone therapy: a randomized, double-blind, multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.520099

Safety and efficacy of drospirenone used in a continuous combination with 17beta-estradiol for prevention of postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.520099

Effects of drospirenone/17-beta estradiol on blood pressure and potassium balance in hypertensive postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.520099

Antihypertensive effects of drospirenone with 17beta-estradiol, a novel hormone treatment in postmenopausal women with stage 1 hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.520099

Drospirenone/ethinyl estradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.520099

Validation of Italian version of the Women's Health Questionnaire: assessment of quality of life of women from the general population and those attending menopause centers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.520099

Effects of low-dose, continuous combined estradiol and noretisterone acetate on menopausal quality of life in early postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.520099

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.520099

Effects of nonoral estradiol-micronized progesterone or low-dose oral estradiol-drospirenone therapy on metabolic variables and markers of endothelial function in early postmenopause

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.520099

Global burden of hypertension: analysis of worldwide data

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.520099

Postmenopausal status according to years since menopause as an independent risk factor for the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.520099

Physiology of hot flashes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.520099

Hot flashes are associated with increased ambulatory systolic blood pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.520099

Climacteric modifications in body weight and fat tissue distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.520099

Summary of the American Heart Association’s Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.520099

Marked improvement in survival after acute myocardial infarction in middle-aged men but not in women. The Northern Sweden MONICA study 1985-94

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.520099

10.3109/13697137.2010.520099

21 January 2018

Identifiers

DOI

1 reference

10 February 2018

PubMed ID

20979461

1 reference

10 February 2018